Categories: News

ProAssurance Corporation Accelerates the Release of First Quarter 2019 Results and Conference Call

BIRMINGHAM, Ala.–(BUSINESS WIRE)–ProAssurance Corporation (NYSE:PRA) will accelerate its reporting of
first quarter 2019 results and will hold an investor call on Friday,
April 26, 2019. This will replace the call originally scheduled for
Friday, May 3, 2019.

Results will be released prior to the call and upon substantial
completion of the quarterly financial close process. We expect to timely
file our quarterly report on Form 10-Q when our usual quarterly
financial close process is finalized.

ProAssurance will now conduct its conference call at 9:00 AM ET on
Friday, April 26, 2019 to discuss the results of the quarter. US-based
investors are invited to participate by phone by dialing (888) 349-0134
(toll-free), Canadian investors may dial (855) 669-9657 (toll free), and
international investors may dial (412) 317-5145. The conference call
will also be webcast through the Investor Relations section of
ProAssurance.com.

We will file our prepared remarks on Form 8-K concurrent with the start
of the conference call. We will file a full transcript of the call to
include answers to questions as soon as practical after the call
concludes. Audio replays will be available shortly after the call ends.

A telephone replay of the call will be available through at least May 1,
2020 using access code 10130644. Investors in the United States may dial
(877) 344-7529 (toll free), Canadian investors may dial (855) 669-9658
(toll free), and international investors may dial (412) 317-0088. A
replay will be available on the internet through at least December 31,
2019 at ProAssurance.com. ProAssurance will make a podcast of the call
available on its website and on iTunes.

About ProAssurance

ProAssurance Corporation is an industry-leading specialty insurer with
extensive expertise in healthcare professional liability, products
liability for medical technology and life sciences, legal professional
liability, and workers’ compensation insurance. The company is
recognized as one of the top performing insurance companies in America
by virtue of our inclusion in the Ward’s 50 for the past twelve years.
ProAssurance Group is rated “A+” (Superior) by A.M. Best; ProAssurance
and its operating subsidiaries are rated “A” (Strong) by Fitch Ratings.

For the latest on ProAssurance and its industry leading suite of
products and services, cutting edge risk management and practice
enhancement programs follow @ProAssurance on Twitter or LinkedIn.
ProAssurance’s YouTube channel regularly presents thought provoking,
insightful videos that communicate effective practice management,
patient safety and risk management strategies.

Contacts

Frank B. O’Neil, IRC
Sr. Vice President, Corporate Communications &
Investor Relations
800-282-6242 • 205-877-4461 • FrankONeil@ProAssurance.com

Staff

Recent Posts

Restart Life Closes Over-Subscribed Second Tranche Financing

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

42 minutes ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 18, 2025) - BioHarvest Sciences Inc.…

42 minutes ago

Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company")…

42 minutes ago

Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.

Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025Toronto, Ontario--(Newsfile Corp. -…

42 minutes ago

Optimi Health Announces Appointment of New Director

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX:…

2 hours ago

Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients

Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke…

3 hours ago